Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1977 2
1978 2
1984 1
1986 1
1987 2
1988 1
1989 2
1991 3
1992 5
1993 1
1994 2
1995 2
1996 4
1997 5
1998 4
1999 2
2000 6
2001 8
2002 6
2003 11
2004 12
2005 11
2006 13
2007 9
2008 7
2009 11
2010 13
2011 13
2012 23
2013 24
2014 25
2015 28
2016 23
2017 17
2018 19
2019 22
2020 21
2021 18
2022 9
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Yasuda S, et al. N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2. N Engl J Med. 2019. PMID: 31475793 Clinical Trial.
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.
Uninterrupted medical care against disasters and pandemics.
Hasebe T, Hasebe N. Hasebe T, et al. Among authors: hasebe n. Hypertens Res. 2024 Feb;47(2):556-558. doi: 10.1038/s41440-023-01524-3. Epub 2023 Dec 4. Hypertens Res. 2024. PMID: 38049613 No abstract available.
The Japanese Society of Hypertension-Digest of plan for the future.
Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S; JSH Future Plan Working Group and Executive Board Members. Node K, et al. Among authors: hasebe n. Hypertens Res. 2018 Dec;41(12):989-990. doi: 10.1038/s41440-018-0111-8. Epub 2018 Oct 11. Hypertens Res. 2018. PMID: 30310169 No abstract available.
[Hypertension].
Hasebe N. Hasebe N. Nihon Rinsho. 2015 Apr;73(4):611-6. Nihon Rinsho. 2015. PMID: 25936149 Japanese.
JSH Statement: Kyoto declaration on hypertension research in Asia.
Ito M, Ishimitsu T, Ichihara A, Itoh H, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Node K, Hasebe N, Higaki J, Miura K, Rakugi H, Tamura K, Kawano Y, Yatabe T, Ohya Y, Ito S. Ito M, et al. Among authors: hasebe n. Hypertens Res. 2019 Jun;42(6):759-760. doi: 10.1038/s41440-018-0172-8. Epub 2019 Jan 7. Hypertens Res. 2019. PMID: 30617311 No abstract available.
NOTCH2NLC mutation-positive neuronal intranuclear inclusion disease with retinal dystrophy: A case report and literature review.
Katayama T, Takahashi K, Yahara O, Sawada J, Ishida KI, Asanome A, Endo H, Saito T, Hasebe N, Kishibe M, Kanno H, Ishiko S, Sone J. Katayama T, et al. Among authors: hasebe n. Medicine (Baltimore). 2023 May 12;102(19):e33789. doi: 10.1097/MD.0000000000033789. Medicine (Baltimore). 2023. PMID: 37171294 Free PMC article. Review.
345 results